METHODS: A male patient was admitted to our hospital in June 2018 and diagnosed with MF via radiological and histopathological examinations. The patient\'s condition was not well controlled by various conventional chemotherapies. US-guided MWA was performed to relieve the patient\'s symptoms and improve his quality of life, showing satisfactory efficacy.
CONCLUSIONS: Eyelid involvement is one of the most troublesome clinical problems for advanced-stage MF patients. This is the first report on the use of US-guided MWA as a palliative therapy for MF eyelid involvement; the treatment successfully relieved the patient\'s clinical symptoms and reduced his anxiety behaviours. Our study sheds new light on methods for improving the clinical management of eyelid involvement in MF.
方法:2018年6月我院收治1例男性患者,经影像学和组织病理学检查确诊为MF。患者的病情不能通过各种常规化疗得到很好的控制。进行美国指导的MWA以减轻患者的症状并改善其生活质量,显示出满意的疗效。
结论:眼睑受累是晚期MF患者最麻烦的临床问题之一。这是关于使用美国指导的MWA作为MF眼睑受累的姑息治疗的第一份报告;该治疗成功地缓解了患者的临床症状并减少了他的焦虑行为。我们的研究为改善MF眼睑受累的临床管理方法提供了新的思路。